🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Desmoplastic Small Round Cell Tumor

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab+liposomal doxorubicin+ifosfamide B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) NCT04897321Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Fludarabine, Cyclophosphamide, MESNA, B7-H3 CAR T cells Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor NCT06456359Phase 24 sites📍 Heidelberg📍 Stuttgart📍 Stuttgart University Hospital Heidelberg · Tests: Signifor Lurbinectedin in FET-Fused Tumors NCT05918640Phase 1, Phase 26 sites📍 Los Angeles📍 Iowa City📍 Boston Children's Hospital of Philadelphia · Tests: Lurbinectedin Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS NCT07328425Phase 25 sites📍 Candiolo📍 Milan📍 Padova Italian Sarcoma Group · Tests: Lurbinectedin, Irinotecan A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites📍 Birmingham📍 Aurora📍 Washington D.C. Nationwide Children's Hospital · Tests: Cabozantinib Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. NCT06836505Phase 1, Phase 23 sites📍 Guangzhou📍 Dongguan📍 Shanghai Sun Yat-Sen University Cancer Center · Tests: CART therapy Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor NCT04690374n/a1 site📍 New York Memorial Sloan Kettering Cancer Center Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas NCT06709495Phase 1, Phase 23 sites📍 Boston📍 Boston📍 Boston David S Shulman, MD · Tests: PEEL-224, Temozolomide, Vincristine, Pegfilgrastim, Filgrastim Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor NCT04616560Phase 232 sites📍 Birmingham📍 Los Angeles📍 Orange National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging, Multigated Acquisition … Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group NCT03967834NA20 sites📍 Besançon📍 Bordeaux📍 Clermont-Ferrand Institut Claudius Regaud · Tests: Patient with Soft Tissue Sarcoma Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site📍 Gainesville University of Florida · Tests: Miltenyi CliniMACS Prodigy ® system, Zoledronic acid
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy